This is the authors' abstract. We don't add key points for this paper.
The RECOVER-VITAL platform protocol has substantial implications for the design and conduct of future Long COVID clinical trials.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zimmerman et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: